• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Inadequate evidence for OTC supplements in preventing cognitive decline

byEvelyn NguyenandDeepti Shroff Karhade
December 22, 2017
in Chronic Disease, Neurology, Psychiatry, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. There was inadequate evidence that any over-the-counter (OTC) supplement helped to prevent or delay decline in cognition.

2. The authors recommend further research using larger scale trials and clinically important outcomes to examine the effects of OTC supplements on cognition.

Evidence Rating Level: 1 (Excellent)   

Study Rundown: Concerns about cognitive decline due to dementia fuels an expanding business for OTC supplements claimed to impede and hinder cognitive decline.  However, evidence is uncertain regarding these claims.  The authors of this systematic review evaluated 38 trials studying the effectiveness of OTC supplements for the prevention or postponement of decline in cognition, mild cognitive impairment (MCI), or Alzheimer-type dementia.  The authors found that there was inadequate evidence that any OTC supplement helped to prevent or delay decline in cognition.  Therefore, health care providers cannot currently recommend any OTC supplement as a protective measure against cognitive decline.  The authors recommend further research using larger scale trials and clinically important outcomes to examine the effects of OTC supplements on cognition.

A strength of the study is that it provides an updated report of the evidence regarding the use of OTC supplements for prevention of dementia or cognitive decline.  Limitations include the evaluation of trials that had short follow-up, high attrition, and greatly varied outcome measures for cognition.

Click to read the study in Annals of Internal Medicine

RELATED REPORTS

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

Incidence and prevalence of dementia among US Medicare beneficiaries between 2015 – 2021

No difference between pharmacologic treatments in age-related macular degeneration risk reduction

Relevant Reading: Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials

In-Depth [systematic review]: The authors used EMBASE, the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, and PsycINFO to search for pertinent literature that was published from January 2009 to July 2017.  To find articles published prior to 2009, the authors examined the citations of certain studies and systematic reviews.  Qualifying studies were in English, had ≥6 months of follow-up, had adult participants who did not have dementia, and evaluated outcomes in cognition for OTC supplements compared to active control or placebo.  The 38 trials that were included had a low to medium risk of bias.  The OTC supplements that were evaluated included B vitamins, vitamin C or beta-carotene, vitamin D plus calcium, ginkgo biloba, multi-ingredient supplements, omega-3 fatty acids, and soy.  Only a small number of studies evaluated the effects of OTC supplements on MCI or clinical Alzheimer-type dementia.  Of those that did, no benefit was shown.  Folic acid and vitamin B12 taken daily was linked to statistically significant results on memory tests, but the clinical significance was uncertain.  Evidence of moderate strength indicated that vitamin E does not improve cognition.  Beta-carotene, vitamin C, vitamin D plus calcium, folic acid alone or in addition to other B vitamins, ginkgo biloba, multivitamins or other supplements with multiple ingredients, omega-3 fatty acids, and soy seem to have no effect on decreasing the risk of cognitive decline, due to evidence regarding the effects of these supplements being of low strength or inadequate.  There was seldom any report of adverse events.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive declinedementia
Previous Post

Inadequate evidence for cognitive training in preventing cognitive decline

Next Post

2 Minute Medicine Rewind December 25, 2017

RelatedReports

Chronic Disease

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

July 2, 2025
Chronic Disease

Incidence and prevalence of dementia among US Medicare beneficiaries between 2015 – 2021

May 31, 2025
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Chronic Disease

No difference between pharmacologic treatments in age-related macular degeneration risk reduction

May 8, 2025
Cardiology

Patients with varicose veins may be at an increased risk of dementia

May 5, 2025
Next Post
Glioblastoma phenotypes identified on MRI predict molecular behavior

2 Minute Medicine Rewind December 25, 2017

Meeting families, demographic information affect child abuse work-up

Kidney failure risk equation (KFRE) discriminates risk in children with chronic kidney disease

Epileptogenic foci may be lateralized using functional brain glutamate imaging

No interventions proven to prevent late-life dementia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke
  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.